Monopar Therapeutics (MNPR) Shares Issued (2017 - 2025)
Quarterly results put Shares Issued at $544800.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $565171.0 (up 672722.62% YoY), and the annual figure for FY2025 was $565171.0, up 672722.62%.
Monopar Therapeutics has reported Shares Issued over the past 7 years, most recently at $544800.0 for Q4 2025.
- Shares Issued reached $544800.0 in Q4 2025 per MNPR's latest filing, up from $20371.0 in the prior quarter.
- Across five years, Shares Issued topped out at $821625.0 in Q1 2023 and bottomed at -$1.5 million in Q3 2023.
- Median Shares Issued over the past 5 years was $16462.5 (2021), compared with a mean of $58290.2.
- The largest annual shift saw Shares Issued plummeted 99.99% in 2024 before it crashed 18489.29% in 2025.
- Over 5 years, Shares Issued stood at $17478.0 in 2021, then crashed by 99.03% to $169.0 in 2022, then tumbled by 875494.08% to -$1.5 million in 2023, then surged by 100.01% to $84.0 in 2024, then surged by 648471.43% to $544800.0 in 2025.
- Business Quant data shows Shares Issued for MNPR at $544800.0 in Q4 2025, $20371.0 in Q3 2025, and -$15447.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 163.10 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Monopar Therapeutics | 466.82 Mn | 466.82 Mn | - | 544,800.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 544,800.00 |
| Dec 31, 2025 | 544,800.00 |
| Sep 30, 2025 | 20,371.00 |
| Sep 30, 2025 | 20,371.00 |
| Jun 30, 2025 | -15,447.00 |
| Jun 30, 2025 | -15,447.00 |
| Mar 31, 2025 | 15,447.00 |
| Mar 31, 2025 | 15,447.00 |
| Jun 30, 2024 | 84.00 |
| Jun 30, 2024 | 84.00 |
| Sep 30, 2023 | -1.48 Mn |
| Sep 30, 2023 | -1.48 Mn |
| Jun 30, 2023 | 657,791.00 |
| Jun 30, 2023 | 657,791.00 |
| Mar 31, 2023 | 821,625.00 |
| Mar 31, 2023 | 821,625.00 |
| Dec 31, 2022 | 169.00 |
| Dec 31, 2022 | 169.00 |
| Mar 31, 2021 | 17,478.00 |
| Mar 31, 2021 | 17,478.00 |
| Sep 30, 2020 | -1.42 Mn |
| Sep 30, 2020 | -1.42 Mn |
| Jun 30, 2020 | 1.42 Mn |
| Jun 30, 2020 | 1.42 Mn |
| Dec 31, 2017 | 10,000.00 |
| Dec 31, 2017 | 10,000.00 |
| Sep 30, 2017 | 2.67 Mn |
| Sep 30, 2017 | 2.67 Mn |
| Jun 30, 2017 | 1.04 Mn |
| Jun 30, 2017 | 1.04 Mn |
| Mar 31, 2017 | 990,002.00 |
| Mar 31, 2017 | 990,002.00 |